Publications by authors named "Elvira Markella Antonogiannaki"

Article Synopsis
  • Depression and anxiety are common issues for patients with idiopathic pulmonary fibrosis (IPF), negatively impacting their quality of life, especially during the COVID-19 pandemic.
  • A study aimed to evaluate how COVID-19 vaccination affects these mental health issues in IPF patients, using the Hospital Anxiety and Depression Scale (HADS) to measure changes before and after vaccination.
  • Results showed a significant improvement in both anxiety and depression scores one month after vaccination, indicating that the vaccine may have beneficial effects on mental health for IPF patients, regardless of factors like age or previous mental health history.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed COVID-19 patients in Greece to compare baseline characteristics and mortality predictors during the Delta and Omicron variant waves.
  • A total of 979 patients were included, with key findings showing Delta patients were younger, required longer hospital stays, and had higher levels of specific biomarkers compared to Omicron patients.
  • Despite these differences, there was no significant disparity in mortality risk or ICU admissions between the two groups; factors such as age and certain medical conditions were identified as independent mortality predictors for the Delta patients.
View Article and Find Full Text PDF

Invasive Aspergillus tracheobronchitis is a relatively rare form of invasive pulmonary aspergillosis characterized by invasion of the tracheobronchial tree by Aspergillus spp. Invasive pulmonary aspergillosis is predominantly detected in severely immunocompromised patients. Notably however, pulmonary and tracheobronchial cases of invasive aspergillosis have also been reported, particularly in the context of severe malaria caused by Plasmodium falciparum.

View Article and Find Full Text PDF

Previous studies have reported very different rates of human rhinovirus (HRV) and respiratory syncytial virus (RSV) genome detection in nasal and sputum samples, but not in bronchoalveolar lavage (BAL) and bronchial biopsy samples. Our study aimed to investigate the presence of HRV and RSV in the lungs of 31 consecutive patients with stable COPD (11 GOLD stage I, 11 II, and 9 III) and 22 control subjects (12 current or past smokers, and 10 non-smokers), who underwent diagnostic (e.g.

View Article and Find Full Text PDF